HK1060354A1 - Variolin derivatives and their use as antitumor agents - Google Patents
Variolin derivatives and their use as antitumor agentsInfo
- Publication number
- HK1060354A1 HK1060354A1 HK04103219A HK04103219A HK1060354A1 HK 1060354 A1 HK1060354 A1 HK 1060354A1 HK 04103219 A HK04103219 A HK 04103219A HK 04103219 A HK04103219 A HK 04103219A HK 1060354 A1 HK1060354 A1 HK 1060354A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- substituted
- antitumor agents
- unsubstituted
- groups
- alkynyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
- Carbon And Carbon Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0116966.3A GB0116966D0 (en) | 2001-07-11 | 2001-07-11 | Anittumoral compounds |
PCT/GB2002/003197 WO2003006457A1 (en) | 2001-07-11 | 2002-07-11 | Variolin derivatives and their use as antitumor agents |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1060354A1 true HK1060354A1 (en) | 2004-08-06 |
Family
ID=9918335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK04103219A HK1060354A1 (en) | 2001-07-11 | 2004-05-07 | Variolin derivatives and their use as antitumor agents |
Country Status (20)
Country | Link |
---|---|
US (2) | US7495000B2 (hu) |
EP (2) | EP1404668B1 (hu) |
JP (1) | JP4369225B2 (hu) |
KR (1) | KR100929616B1 (hu) |
CN (1) | CN1553906B (hu) |
AT (2) | ATE396987T1 (hu) |
AU (1) | AU2002317329B2 (hu) |
CA (1) | CA2453418C (hu) |
DE (2) | DE60226869D1 (hu) |
ES (2) | ES2354991T3 (hu) |
GB (1) | GB0116966D0 (hu) |
HK (1) | HK1060354A1 (hu) |
HU (1) | HUP0402658A2 (hu) |
IL (2) | IL159792A0 (hu) |
MX (1) | MXPA04000355A (hu) |
NO (1) | NO328848B1 (hu) |
NZ (1) | NZ530556A (hu) |
PL (1) | PL366894A1 (hu) |
RU (1) | RU2302419C2 (hu) |
WO (1) | WO2003006457A1 (hu) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1299388T3 (da) | 2000-07-11 | 2009-08-31 | Pharma Mar Sa | Variolin-derivater som anti-cancermidler |
GB0019117D0 (en) | 2000-08-03 | 2000-09-27 | Univ Barcelona | Derivatives of variolin B |
GB0116966D0 (en) | 2001-07-11 | 2001-09-05 | Pharma Mar Sa | Anittumoral compounds |
DK2300475T3 (en) * | 2008-06-11 | 2014-12-08 | Genentech Inc | Diazacarbazoler and methods of using |
JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1299388T3 (da) * | 2000-07-11 | 2009-08-31 | Pharma Mar Sa | Variolin-derivater som anti-cancermidler |
GB0019117D0 (en) * | 2000-08-03 | 2000-09-27 | Univ Barcelona | Derivatives of variolin B |
GB0116966D0 (en) | 2001-07-11 | 2001-09-05 | Pharma Mar Sa | Anittumoral compounds |
-
2001
- 2001-07-11 GB GBGB0116966.3A patent/GB0116966D0/en not_active Ceased
-
2002
- 2002-07-11 EP EP02745614A patent/EP1404668B1/en not_active Expired - Lifetime
- 2002-07-11 US US10/483,525 patent/US7495000B2/en not_active Expired - Fee Related
- 2002-07-11 NZ NZ530556A patent/NZ530556A/en not_active IP Right Cessation
- 2002-07-11 EP EP07013582A patent/EP1867645B1/en not_active Expired - Lifetime
- 2002-07-11 AU AU2002317329A patent/AU2002317329B2/en not_active Ceased
- 2002-07-11 JP JP2003512229A patent/JP4369225B2/ja not_active Expired - Fee Related
- 2002-07-11 MX MXPA04000355A patent/MXPA04000355A/es active IP Right Grant
- 2002-07-11 DE DE60226869T patent/DE60226869D1/de not_active Expired - Lifetime
- 2002-07-11 AT AT02745614T patent/ATE396987T1/de not_active IP Right Cessation
- 2002-07-11 AT AT07013582T patent/ATE480533T1/de not_active IP Right Cessation
- 2002-07-11 ES ES07013582T patent/ES2354991T3/es not_active Expired - Lifetime
- 2002-07-11 CN CN028175298A patent/CN1553906B/zh not_active Expired - Fee Related
- 2002-07-11 RU RU2004103857/04A patent/RU2302419C2/ru not_active IP Right Cessation
- 2002-07-11 KR KR1020047000500A patent/KR100929616B1/ko not_active IP Right Cessation
- 2002-07-11 CA CA2453418A patent/CA2453418C/en not_active Expired - Fee Related
- 2002-07-11 PL PL02366894A patent/PL366894A1/xx not_active Application Discontinuation
- 2002-07-11 ES ES02745614T patent/ES2307768T3/es not_active Expired - Lifetime
- 2002-07-11 HU HU0402658A patent/HUP0402658A2/hu unknown
- 2002-07-11 WO PCT/GB2002/003197 patent/WO2003006457A1/en active IP Right Grant
- 2002-07-11 IL IL15979202A patent/IL159792A0/xx unknown
- 2002-07-11 DE DE60237652T patent/DE60237652D1/de not_active Expired - Lifetime
-
2004
- 2004-01-11 IL IL159792A patent/IL159792A/en not_active IP Right Cessation
- 2004-01-12 NO NO20040113A patent/NO328848B1/no not_active IP Right Cessation
- 2004-05-07 HK HK04103219A patent/HK1060354A1/xx not_active IP Right Cessation
-
2009
- 2009-01-07 US US12/349,813 patent/US7772241B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA04001240A (es) | Analogos antitumorales. | |
IL144461A0 (en) | Quinoline and quinazoline derivatives and pharmaceutical compositions containing them | |
HK1039727A1 (en) | Synthetic analogs of ecteinascidin-743 | |
DK0918776T3 (da) | Totalsyntese af antitumor acylfulvener | |
CY1109283T1 (el) | Παραγωγα βαριολινης ως αντικαρκινικα μεσα | |
CY1113359T1 (el) | Αντι-νεοπλασιακα παραγωγα του et-743 | |
MXPA02006329A (es) | 8-arilquinolinas sustituidas que son inhibidores de fosfodiesterasa-4. | |
HK1060354A1 (en) | Variolin derivatives and their use as antitumor agents | |
GB2334032A (en) | Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents | |
AU3387301A (en) | Oxy-and amino-substituted tetrahydrofuryl derivatives with antitumour activity | |
IL166484A0 (en) | Myriaporone derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20120711 |